$22.40
-0.47%Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Chief Compliance Officer
Chief Executive Officer & Director
Compensation
$3,386,188
Chief Human Resources officer
Chief Information Officer
President of Diagnostics
Compensation
$898,750
Senior Vice President & Chief Financial Officer
Compensation
$2,807,847
Senior Vice President of Strategy & Corporate Development
Compensation
$848,850
Senior Vice President, General Counsel & Secretary
Compensation
$988,738
Vice President of Investor Relations
Vice President, Chief Accounting Officer & Corporate Controller
During the last 12 months, insiders have sold $493K worth of NVST shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
5.6K
169.02K
-169K
-$169K
0
0.00
0
0.00
+0
+$0
0
0.00
15.0K
324.00K
-324K
-$324K
No buying activity
Reis Mischa
Officer: Svp, Strategy & Bus. Dev.
$493K
Strong bearish signal with $493K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
1 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
NVST - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | April 07, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | April 24, 2025 | June 10, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 08, 2024 | May 21, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 10, 2023 | April 10, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 13, 2022 | May 24, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 12, 2021 | May 25, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 14, 2020 | May 27, 2020 | 2020 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.